Published in Biochem Pharmacol on June 01, 1982
The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest (1984) 3.26
Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. Am J Pathol (1986) 1.15
Pulmonary leukosequestration induced by hind limb ischemia. Ann Surg (1987) 1.09
Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway. Filaria J (2005) 0.99
Leukotrienes but not complement mediate limb ischemia-induced lung injury. Ann Surg (1989) 0.90
Uveitis induction in the rabbit by muramyl dipeptides. Infect Immun (1986) 0.89
Limb ischemia-induced increase in permeability is mediated by leukocytes and leukotrienes. Ann Surg (1988) 0.85
Pharmacological modulation of activation-secretion of rat serosal mast cells by chymase, an endogenous secretory granule protease. Immunology (1985) 0.80
Diethylcarbamazine citrate, an antifilarial drug, stimulates human granulocyte adherence. Antimicrob Agents Chemother (1983) 0.78
Roles of 5-lipoxygenase and cysteinyl-leukotriene type 1 receptors in the hematological response to allergen challenge and its prevention by diethylcarbamazine in a murine model of asthma. Mediators Inflamm (2014) 0.78
Diethylcarbamazine attenuates the development of carrageenan-induced lung injury in mice. Mediators Inflamm (2014) 0.76
α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95. Br J Pharmacol (2015) 0.76
Modulation of equine platelet function by diethylcarbamazine (DEC). Am J Pathol (1983) 0.75
Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature (1999) 5.48
Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A (1979) 5.33
The Function of Ac-Globulin in Blood Clotting. Science (1947) 2.62
The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis. J Immunol (1973) 2.34
Structure of leukotriene C. Identification of the amino acid part. Biochem Biophys Res Commun (1979) 2.30
Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A (1991) 2.20
Inactivation of slow reacting substance of anaphylaxins (SRS-A) by arylsulfatases. J Immunol (1974) 2.19
Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis. Aliment Pharmacol Ther (2014) 2.18
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem (2001) 1.86
Nonimmunological production of leukotrienes induced by platelet-activating factor. Science (1982) 1.58
Crystal structure of the SarR protein from Staphylococcus aureus. Proc Natl Acad Sci U S A (2001) 1.48
Trehalose-containing lipooligosaccharides. A new class of species-specific antigens from Mycobacterium. J Biol Chem (1983) 1.41
Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol (1998) 1.39
Remodeling of arachidonate-containing phosphoglycerides within the human neutrophil. J Biol Chem (1986) 1.37
Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J Biol Chem (1990) 1.32
Leukotriene generation by eosinophils. J Exp Med (1982) 1.29
Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J Biol Chem (1999) 1.25
Transcellular metabolism of neutrophil-derived leukotriene A4 by human platelets. A potential cellular source of leukotriene C4. J Biol Chem (1988) 1.25
Electrospray mass spectrometric analysis of 5-hydroperoxy and 5-hydroxyeicosatetraenoic acids generated by lipid peroxidation of red blood cell ghost phospholipids. J Am Soc Mass Spectrom (1998) 1.25
Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. Pharmacol Rev (1988) 1.21
Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETs). Arch Biochem Biophys (1985) 1.21
Isocratic separation of some purine nucleotide, nucleoside, and base metabolites from biological extracts by high-performance liquid chromatography. J Chromatogr (1976) 1.20
Leukotrienes and slow reacting substance of anaphylaxis (SRS-A). Allergy (1980) 1.19
Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J Biol Chem (1999) 1.16
Introduction of a nomenclature: leukotrienes. Prostaglandins (1979) 1.16
Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem (1998) 1.16
Identification of functional platelet-activating factor receptors on human keratinocytes. J Invest Dermatol (1995) 1.15
Leukotrienes: a new group of biologically active compounds. Adv Prostaglandin Thromboxane Res (1980) 1.15
Analysis of epoxyeicosatrienoic and monohydroxyeicosatetraenoic acids esterified to phospholipids in human red blood cells by electrospray tandem mass spectrometry. J Mass Spectrom (1997) 1.14
Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res (1983) 1.14
Phosphatidylethanolamine has an essential role in Saccharomyces cerevisiae that is independent of its ability to form hexagonal phase structures. J Biol Chem (2001) 1.13
Fast atom bombardment tandem mass spectrometric identification of diacyl, alkylacyl, and alk-1-enylacyl molecular species of glycerophosphoethanolamine in human polymorphonuclear leukocytes. Anal Chem (1992) 1.13
Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med (1983) 1.11
Bioactive phospholipid oxidation products. Free Radic Biol Med (2000) 1.11
12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea. Proc Natl Acad Sci U S A (1987) 1.11
Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am J Physiol (1985) 1.06
The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest (1999) 1.05
Molecular cloning and characterization of the recA gene from the cyanobacterium Synechococcus sp. strain PCC 7002. J Bacteriol (1987) 1.05
Leukotriene E4 elimination and metabolism in normal human subjects. J Biol Chem (1990) 1.04
Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat. Free Radic Biol Med (1997) 1.03
Analysis of 6-keto PGF1 alpha, 5-HETE, and LTC4 in rat lung: comparison of GM/MS, RIA, and EIA. Prostaglandins (1986) 1.03
Synthesis and back exchange of 18O labeled amino acids for use as internal standards with mass spectrometry. Biomed Mass Spectrom (1979) 1.03
Preparation of labeled molecules by exchange with oxygen-18 water. Methods Enzymol (1990) 1.02
Analysis of leukotrienes by high-pressure liquid chromatography. Anal Biochem (1981) 1.02
Oxidation of docosahexaenoic acid by rat liver microsomes. J Biol Chem (1984) 1.01
Tetraene and pentaene leukotrienes: selective production from murine mastocytoma cells after dietary manipulation. Prostaglandins (1981) 1.01
Leukotriene C4 and D4 formation by particulate enzymes. J Biol Chem (1982) 1.00
Amino acid sequence of thioredoxin isolated from rabbit bone marrow determined by tandem mass spectrometry. J Biol Chem (1988) 0.99
Direct mass spectrometric analysis of ozonides: application to unsaturated glycerophosphocholine lipids. Anal Chem (1996) 0.99
Bladder explosions during transurethral surgery. J Urol (1975) 0.99
Reversible membrane association of neutrophil 5-lipoxygenase is accompanied by retention of activity and a change in substrate specificity. J Biol Chem (1992) 0.99
N-acylkansosamine. A novel N-acylamino sugar from the trehalose-containing lipooligosaccharide antigens of Mycobacterium kansasii. J Biol Chem (1984) 0.98
Electrophysiological response of cerebellar Purkinje neurons to leukotriene D4 and B4. J Pharmacol Exp Ther (1981) 0.98
Analysis of oxidized glycerophosphocholine lipids using electrospray ionization mass spectrometry and microderivatization techniques. J Mass Spectrom (2000) 0.98
Mediator release after endobronchial antigen challenge in patients with respiratory allergy. J Allergy Clin Immunol (1990) 0.97
A new explanation for the progressive tissue loss in electrical injuries. Plast Reconstr Surg (1984) 0.97
Extramedullary hematopoiesis in a child with hereditary spherocytosis: an uncommon cause of an adrenal mass. Pediatr Radiol (2001) 0.97
Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids. J Biol Chem (1992) 0.97
On the metabolic acidosis of ethylene glycol intoxication. Toxicol Appl Pharmacol (1977) 0.97
FMLP causes eicosanoid-dependent vasoconstriction and edema in lungs from endotoxin-primed rats. Am Rev Respir Dis (1992) 0.96
The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice. Toxicology (2001) 0.96
Identification and functional characterization of leukotriene B4 20-hydroxylase of human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1985) 0.96
Electrospray ionization mass spectrometry of lysoglycerophosphocholine lipid subclasses. J Am Soc Mass Spectrom (2000) 0.96
Role of calcium-activated K+ channels in vasodilation induced by nitroglycerine, acetylcholine and nitric oxide. J Pharmacol Exp Ther (1993) 0.96
Purification of an endogenous digitalislike factor from human plasma for structural analysis. Hypertension (1991) 0.95
Isoleukotrienes are biologically active free radical products of lipid peroxidation. J Biol Chem (1995) 0.95
Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells. J Biol Chem (1991) 0.94
Structural characterization of oxidized phospholipid products derived from arachidonate-containing plasmenyl glycerophosphocholine. J Lipid Res (2000) 0.94
Fast atom bombardment analysis of arachidonic acid-containing phosphatidylcholine molecular species. Biomed Environ Mass Spectrom (1986) 0.94
Inhibition by aspirin of bronchoconstriction due to leukotrienes C4 and D4 in the guinea pig. Eur J Pharmacol (1981) 0.93
Transcellular sulfidopeptide leukotriene biosynthetic capacity of vascular cells. Blood (1989) 0.93
Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance. J Clin Invest (1981) 0.93
Differential metabolism of exogenous and endogenous arachidonic acid in human neutrophils. J Biol Chem (1999) 0.92
Analysis of lipid hydroperoxides and long-chain conjugated keto acids by negative ion electrospray mass spectrometry. J Am Soc Mass Spectrom (1995) 0.92
Susceptibility of plasmenyl glycerophosphoethanolamine lipids containing arachidonate to oxidative degradation. Free Radic Biol Med (1999) 0.92
Electron capture negative ion chemical ionization analysis of arachidonic acid. Biomed Environ Mass Spectrom (1988) 0.92
Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes. J Invest Dermatol (1989) 0.92
Gastric carcinoid and gastric carcinoma. Morphologic correlates of survival. Am J Surg Pathol (1979) 0.92
Altering hydrodynamic variables influences PGI2 production by isolated lungs and endothelial cells. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.91
Analysis of phospholipid molecular species in rat lung as dinitrobenzoate diglycerides by electron capture negative chemical ionization mass spectrometry. Biomed Environ Mass Spectrom (1987) 0.91
Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. Am Rev Respir Dis (1987) 0.91
Evidence that S-nitrosothiols are responsible for the smooth muscle relaxing activity of the bovine retractor penis inhibitory factor. J Pharmacol Exp Ther (1992) 0.91
Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry. J Neurochem (2001) 0.91
Endotoxin-induced lung injury in rats: role of eicosanoids. J Appl Physiol (1985) (1989) 0.91
Electrospray ionization and low energy tandem mass spectrometry of polyhydroxy unsaturated fatty acids. J Am Soc Mass Spectrom (1996) 0.90
Metabolism of leukotriene B4 in isolated rat hepatocytes. Identification of a novel 18-carboxy-19,20-dinor leukotriene B4 metabolite. J Biol Chem (1986) 0.90
Autooxidation of docosahexaenoic acid: analysis of ten isomers of hydroxydocosahexaenoate. J Lipid Res (1984) 0.90
The structure of tyrosine aminotransferase. Evidence for domains involved in catalysis and enzyme turnover. J Biol Chem (1989) 0.90
Structure elucidation of platelet activating factor derived from human neutrophils. Biochem Biophys Res Commun (1984) 0.90
Experimental methanol toxicity in the primate: analysis of metabolic acidosis. Toxicol Appl Pharmacol (1975) 0.89
Rapid extraction of leukotrienes from biologic fluids and quantitation by high-performance liquid chromatography. J Chromatogr (1982) 0.89
Leukotriene C elicits a prolonged excitation of cerebellar Purkinje neurons. Neurosci Lett (1980) 0.89
Discovery and development of the N-terminal procollagen type II (NPII) biomarker: a tool for measuring collagen type II synthesis. Osteoarthritis Cartilage (2008) 0.89
Analysis of stable oxidized molecular species of glycerophospholipids following treatment of red blood cell ghosts with t-butylhydroperoxide. Anal Biochem (1998) 0.88
Site-specific chemical modification of interleukin-1 beta by acrylodan at cysteine 8 and lysine 103. J Biol Chem (1992) 0.88
Low-energy fast atom bombardment tandem mass spectrometry of monohydroxy substituted unsaturated fatty acids. Biol Mass Spectrom (1993) 0.88
Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL. Arterioscler Thromb Vasc Biol (1997) 0.88
Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism. J Immunol (1989) 0.88